12 completed. 12 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 12 |
| Phase 2 | 3 | Completed 3 |
Follow Myalgia: new trials by email Literature Review of Myalgia trials Research Report on Myalgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population Maolactin, Maltodextrin - Chronic Inflammation, Mobility | Phase 3 | Completed | RDC Clinical Pty Ltd | 97 | 2025-02-27 | 2026-03-06 |
| Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population Maolactin, Maltodextrin - Post Exercise Inflammation, Exercise Recovery | Phase 3 | Completed | RDC Clinical Pty Ltd | 33 | 2024-09-12 | 2025-06-25 |
| The Effect of Pretreatment With Roc on Succinylcholine Myalgias non-pretreated Succinylcholine, succinylcholine 1 minute after rocuronium pretreatment, succinylcholine 2 minutes following rocuronium pretreatment - Myalgia | Phase 3 | Completed | Indiana University | 300 | 2020-10-02 | 2024-08-21 |
| The Platelet-Rich Plasma in the Therapy of Temporomandibular Disorders Platelet-Rich Plasma intramuscular injections, Placebo Comparator: 0,9% NaCl intramuscular injections - PRP, Temporomandibular Disorder | Phase 2 / Phase 3 | Completed | Medical University of Silesia | 58 | 2017-12-07 | 2019-01-04 |
| Belimumab in Idiopathic Inflammatory Myositis Belimumab, Placebo - Myositis | Phase 2 / Phase 3 | Completed | Northwell Health | 17 | 2015-01-01 | 2024-02-09 |
| A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness Diclofenac sodium gel 1%, Placebo - Muscle Soreness | Phase 3 | Completed | Novartis | 102 | 2014-10-01 | 2016-04-05 |
| Effects of Cisatracurium on Succinylcholine-induced Fasciculations and Myalgia Cisatracurium - Fasciculation | Phase 3 | Completed | Yangzhou No.1 People's Hospital | 90 | 2013-03-01 | 2015-06-25 |
| Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms Coenzyme Q10, Placebo - Pain, Weakness | Phase 2 / Phase 3 | Completed | Catherine Buettner | 68 | 2009-12-01 | 2017-01-23 |
| Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Peramivir - Seasonal Influenza, Cough | Phase 3 | Completed | BioCryst Pharmaceuticals | 234 | 2009-10-01 | 2015-02-12 |
| A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. placebo, Xyrem® - Fibromyalgia | Phase 3 | Completed | Jazz Pharmaceuticals | 573 | 2006-12-01 | 2012-01-24 |
| Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. Xyrem® - Fibromyalgia | Phase 3 | Completed | Jazz Pharmaceuticals | 560 | 2006-12-01 | 2012-03-30 |
| A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia Xyrem®, Placebo - Fibromyalgia | Phase 3 | Completed | Jazz Pharmaceuticals | 548 | 2006-08-01 | 2011-12-29 |
Arthralgia (4) · Pain (4) · Fibromyalgia (3) · Fasciculation (2) · Asthenia (1) · Bruxism (1) · Cough (1) · Dermatomyositis (1) · Fatigue (1) · Headache (1) · Influenza, Human (1) · Muscle Cramp (1) · Muscle Weakness (1) · Myositis (1)
Muscular Diseases (12) · Musculoskeletal Diseases (12) · Musculoskeletal Pain (12) · Nervous System Diseases (12) · Neurologic Manifestations (12) · Neuromuscular Diseases (12) · Pathological Conditions, Signs and Symptoms (12) · Signs and Symptoms (12) · Pain (8) · Joint Diseases (5) · Neuromuscular Manifestations (3) · Rheumatic Diseases (3) · Stomatognathic Diseases (2) · Airway Obstruction (1) · Behavior (1)
Sodium Oxybate (3) · maltodextrin (2) · Control Groups (1) · Succinylcholine (1) · belimumab (1) · cisatracurium (1) · coenzyme Q10 (1) · peramivir (1)
Jazz Pharmaceuticals (3) · RDC Clinical Pty Ltd (2) · BioCryst Pharmaceuticals (1) · Catherine Buettner (1) · Indiana University (1) · Medical University of Silesia (1) · Northwell Health (1) · Novartis (1) · Yangzhou No.1 People's Hospital (1)
United States (8) · Australia (3) · France (2) · Germany (2) · Italy (2) · Netherlands (2) · Poland (2) · Spain (2) · United Kingdom (2) · Canada (1) · Mexico (1) · New Zealand (1) · Puerto Rico (1)
David Briskey, PhD (2) · Aleksandra Nitecka-Buchta, DMD (1) · Catherine Buettner, MD, MPH (1) · Galina Marder, MD (1) · I. Jon Russell, PhD, MD (1) · Leighan Bye, MD (1)
PMID 19116896, PMID 21397402, PMID 23985625, PMID 24286114, PMID 37326854
K23AR055664 (1)